Vaccine (BASKET)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vaccine (BASKET).php on line 2
Vaccine (BASKET)

LE WE PMID CA

Vaccine (BASKET)

4706

Impfstoff (allg)

Avipoxviruses

Bacillus subtilis

Biofilm (Microbiology)

CpG Oligonucleotides

Dendritic cell (Myeloid)

HLA and MHC

Human papilloma virus

MDA5

NLRP3

Norovirus

Rabies

RNA (dsRNA)

T cell (Th17)

TLR3

Vaccine (BASKET)

1974 1	Vaccines and cell-mediated immunity. [4613342] Bacteriol Rev 38(4): 371-402 (1974)
2010 2	Application of nanotechnologies for improved immune response against infectious diseases in the developing world. [19922750] Adv Drug Deliv Rev 62(4-5): 378-93 (2010)
2009 3	Innovative strategies for co-delivering antigens and CpG oligonucleotides. [19272328] Adv Drug Deliv Rev 61(3): 205-17 (2009)
2010 4	Emerging vaccine informatics. [21772787] J Biomed Biotechnol 2010(-): 218590 (2010)
2010 5	Vaccine informatics. [21772788] J Biomed Biotechnol 2010(-): 765762 (2010)
2010 6	Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant. [20671921] J Biomed Biotechnol 2010(-): 690438 (2010)
2010 7	High throughput T epitope mapping and vaccine development. [20617148] J Biomed Biotechnol 2010(-): 325720 (2010)
2010 8	Viral vaccines and CTL response. [20379365] J Biomed Biotechnol 2010(-): 141657 (2010)
2007 9	Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination. [17437418] Clin Exp Immunol 148(2): 199-207 (2007)
2011 10	Avipoxviruses: infection biology and their use as vaccine vectors. [21291547] Virol J 8(-): 49 (2011)
2010 11	Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system. [20508245] Microbiol Mol Biol Rev 74(2): 157-70 (2010)
2005 12	Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors. [15692682] An Acad Bras Cienc 77(1): 113-24 (2005)
2010 13	Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. [20602638] FEMS Immunol Med Microbiol 59(3): 306-23 (2010)
2008 14	Exploiting cholera vaccines as a versatile antigen delivery platform. [18008168] Biotechnol Lett 30(4): 571-9 (2008)
2010 15	Recent advances in B-cell epitope prediction methods. [21067544] Immunome Res 6 Suppl 2(-): S2 (2010)
2010 16	Th17 cytokines and vaccine-induced immunity. [20112107] Semin Immunopathol 32(1): 79-90 (2010)
2011 17	Vaccination with transgenic rice seed expressing mite allergen: a new option for asthma sufferers? [21919612] Expert Rev Vaccines 10(9): 1249-51 (2011)
2011 18	Protecting the initial site of viral entry: an alternative HIV vaccine target. [21919613] Expert Rev Vaccines 10(9): 1253-6 (2011)
2010 19	Defining immune memory resilience: implications for vaccine development. [20370544] Expert Rev Vaccines 9(4): 351-3 (2010)
2010 20	Norwalk virus-like particles as vaccines. [20218858] Expert Rev Vaccines 9(3): 299-307 (2010)
2009 21	Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines. [19348562] Expert Rev Vaccines 8(4): 469-81 (2009)
2009 22	Use of hepadnavirus core proteins as vaccine platforms. [19863249] Expert Rev Vaccines 8(11): 1565-73 (2009)
2010 23	Correlates of protection induced by vaccination. [20463105] Clin Vaccine Immunol 17(7): 1055-65 (2010)
2005 24	Recombinant poxviruses as mucosal vaccine vectors. [16227213] J Gen Virol 86(Pt 11): 2925-36 (2005)
2011 25	Combination vaccines. [21572611] J Glob Infect Dis 3(1): 63-72 (2011)
2011 26	Fundamentals of vaccine immunology. [21572612] J Glob Infect Dis 3(1): 73-8 (2011)
2008 27	MHC and MHC-like molecules: structural perspectives on the design of molecular vaccines. [18728400] Hum Vaccin 4(6): 400-9 (2008)
2008 28	HSV as a vector in vaccine development and gene therapy. [18496918] Hum Vaccin 4(2): 91-105 (2008)
2010 29	Vaccination strategies to promote mucosal antibody responses. [21029959] Immunity 33(4): 479-91 (2010)
2010 30	Systems vaccinology. [21029962] Immunity 33(4): 516-29 (2010)
2010 31	Induction of immunity to human immunodeficiency virus type-1 by vaccination. [21029964] Immunity 33(4): 542-54 (2010)
2010 32	Vaccines based on whole recombinant Saccharomyces cerevisiae cells. [20707820] FEMS Yeast Res 10(8): 1060-9 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vaccine (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vaccine (BASKET).php on line 92